DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Age-Related Macular Degeneration epidem…
Author: Business Wire
OneLegacy to Host Nation’s Largest Donation and Transplantation Symposium October 30 in Pomona
LOS ANGELES–(BUSINESS WIRE)–#donatelife–OneLegacy will host its ninth annual “Donation & Transplantation Symposium” October 30 at the Sheraton Fairplex Hotel and Convention Center in Pomona.
Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO) (“Aerpio”) today announced that its common stock will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018, following its previously announced approval to list its common stock on the Nasdaq Capital Market. Aerpio also announced today the pricing of the previously announced underwritten public offering of 11,688,000 shares of its common stock at a price to the public o
EyeQue Raises $11.2 Million in Series B to Bring At-Home Vision Testing to the Masses
NEWARK, Calif.–(BUSINESS WIRE)–#AtHomeVisionTesting–EyeQue has raised $11.2 million dollars in Series B investment to further fuel the mission of bringing affordable at-home vision tests to the masses.
TSYS and Eye Care Leaders Envision a Bright Future Together
COLUMBUS, Ga.–(BUSINESS WIRE)–#EyeCareLeaders–More than 8,000 ophthalmologists and optometrists will now have access to integrated payment solutions thanks to TSYS and Eye Care Leaders.
STAAR Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic Cooperation Agreement
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Kobe Kanagawa Eye Clinic with locations in Tokyo and Osaka, today announced they have entered into a multi-year Strategic Cooperation Agreement to provide STAAR’s EVO Visian ICL™ lenses as a primary and premium option for patients seeking visual freedom from spectacles and contact lenses through refractive
Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO) (“Aerpio”) today announced that it intends to sell, subject to market and other conditions, $40 million of its common stock in an underwritten public offering. Aerpio also intends to grant the underwriters a 30-day option to purchase an additional fifteen percent (15%) of the shares of its common stock offered in the public offering. Aerpio also announced that its common stock has been approved for listing on the Nasdaq Capi
Glaukos Announces FDA Approval for the iStent inject® Trabecular Micro-Bypass System
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the iStent inject® Trabecular Micro-Bypass System indicated for the reduction of intraocular
Presbyopia – A Pipeline Analysis Report 2018| Technavio
LONDON–(BUSINESS WIRE)–#InfectiousDiseases–Technavio has published a new report on the drug development pipeline for presbyopia, including a detailed study of the pipeline molecules.
Visioneering Technologies Unveils NaturalVue® Sphere with Comfort Enhancers At American Optometric Association Meeting
DENVER–(BUSINESS WIRE)–Visioneering Technologies announced the addition of comfort enhancers to NaturalVue® Sphere 1 Day Contact Lenses and presented clinical data at AOA.
Visioneering Technologies Launches NaturalVue Multifocal Contact Lenses in Plus Powers
DENVER–(BUSINESS WIRE)–Visioneering Technologies, Inc. announced at AOA the availability of NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses in Plus Powers.
Global Eyeglasses (Lenses, Frames & Sunglasses) Strategic Business Report 2018: Annual Estimates & Forecasts 2016-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyeglasses – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America,…
New Clinical Studies Live on Veeva Vault EDC
PLEASANTON, Calif.–(BUSINESS WIRE)–#EDC–In just over a year since the product’s availability, 12 early adopters have initiated studies with Vault EDC, including a top 20 global pharma.
New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathy
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today new data on the effect of emixustat hydrochloride on retinal thickness in diabetic retinopathy (DR). The study (Protocol 4429-203) is a randomized, placebo-controlled, phase 2 clinical trial exploring the effect of oral emixustat hydrochloride in a proliferative diabetic retinopathy (PDR) population with
China Cancer Drug Market (2018) Size, Trends, Key Opportunities & Forecast to 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Cancer Drug Market: Size, Trends & Forecasts (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. The report provides analysis of the China cancer drug market, with detailed analysis of market size and growth, and value of the industry. The analysis includes the market by value, by cases and incidence ratio. Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the
2018 Global Glaucoma Epidemiology & Patient Flow Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucom…
Global Eyewear Market 2017-2018 to 2023: by Product Type, Mode of Sale, Region – Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market – by Product Type, Mode of Sale, Region – Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The glob…
Intraocular Lenses (Standard & Premium): Global Strategic Business Report 2016-2018 to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lenses – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin…
NuSight Medical® Launches NuLids™ for the Treatment of Dry Eye
RANCHO SANTA FE, Calif.–(BUSINESS WIRE)–NuLids, a medical device that treats dry eyes, is being launched at the American Optometric Assoc. meeting. Dry eye affects over 1/3 of Americans.
Bio-Tissue, Inc. Highlights Publication of DREAM Study
MIAMI–(BUSINESS WIRE)–#Eye–Bio-Tissue, a TissueTech company, highlighted the publication of the DRy Eye Amniotic Membrane (DREAM) study in Clinical Ophthalmology.